Delivery Order SPE2DB22D3301-SPE2DB25FX4QA

Award Date 10/29/24
Potential Completion Date 10/30/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXMETHYLPHENIDATE ER 10 MG CP 100S, a prescription medication, with a ceiling value of $2,774.78 and a completion date of May 23, 2025. The contract is a firm fixed-price type, and it is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, is for the delivery of DEXMETHYLPHENIDATE ER 10 MG CP 100S, a prescription medication. The contract has a ceiling value of $2,389.31 and a completion date of July 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DEXMETHYLPHENIDATE ER 15 MG CP 100S, a prescription medication, with a ceiling value of $5,722.34. The contract is a Firm Fixed Price (FFP) type and does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DEXMETHYLPHENIDATE ER 25 MG CP 100S. The contract has a ceiling value of $1,081.76 and a period of performance through May 17, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of DEXMETHYLPHENIDATE ER capsules, 25 mg, with a ceiling value of $2,555.49 and a completion date of March 7, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and holds a larger Indefinite...
This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,644.76 firm fixed-price contract is for the delivery of DEXMETHYLPHENIDATE ER 5 MG CAP 100S, a specialty medication, with a period of performance through April 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,010.91, is for the supply of DEXMETHYLPHENIDATE ER 20 MG CP 100S, a pharmaceutical product. The contract is a firm-fixed-price delivery order with a period of performance through November 15, 2024. No set-aside requirements were noted. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DEXMETHYLPHENIDATE ER 20 MG CP 100S. The contract has a ceiling value of $1,198.23 and a completion date of March 31, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of DEXMETHYLPHENIDATE ER 20 MG CP 100S, a medical product, with a ceiling value of $1,913.34 and an ultimate completion date of January 6, 2025. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,329.10, is for the delivery of DEXMETHYLPHENIDATE ER 10 MG CP 100S, a generic pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of March 25, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX4QA
    Delivery Order

This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXMETHYLPHENIDATE ER 10 MG CP 100S, a medication, with a ceiling value of $2,814.04 and an ultimate completion date of October 30, 2024. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 IDC with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/20/25, 2:22 PM